The infectivity of transmissible spongiform encephalopathy agent at low doses: The importance of phospholipid

Journal of Applied Microbiology

Volumn 101, Issue 2, 2006, Pages 261-274

  Gale, P ^a  

^a NONE   (United Kingdom)

Author keywords

Bovine spongiform encephalopathy; Co operative action; Dose response; Incubation period; Protein lipid interactions; Risk assessment

Indexed keywords

NEURODEGENERATIVE DISEASES; NUCLEATION; PRASEODYMIUM COMPOUNDS; PROTEINS; RISK ASSESSMENT; SODIUM HYDROXIDE;

BOVINE SPONGIFORM ENCEPHALOPATHY; CO-OPERATIVE ACTION; DOSE RESPONSE; INCUBATION PERIODS; LOW DOSE; NUCLEATION SEEDS; PRION PROTEIN; PROTEIN-LIPID INTERACTIONS; RISKS ASSESSMENTS; SPONGIFORM ENCEPHALOPATHIES;

PHOSPHOLIPIDS;

ALKALI; BACTERIORHODOPSIN; MEMBRANE PROTEIN; NUCLEIC ACID; PHOSPHOLIPID; PRION PROTEIN;

GENOTYPE; INFECTIVITY; NUCLEATION; PHOSPHOLIPID; PROTEIN; RISK ASSESSMENT; TRANSMISSIVITY;

AUTOCLAVE; BRAIN SPONGIOSIS; COMPUTER SIMULATION; ENVIRONMENTAL EXPOSURE; FOOD SAFETY; GENETIC HETEROGENEITY; GENOTYPE; HEATING; HUMAN; INFECTION; NONHUMAN; PHENOTYPE; PROTEIN AGGREGATION; PROTEIN INTERACTION; PUBLIC HEALTH; REVIEW; RISK; RISK ASSESSMENT; SALMONELLA TYPHIMURIUM; SCRAPIE; THERMOSTABILITY;

IPS;

EID: 33745947269     PISSN: 13645072     EISSN: 13652672     Source Type: Journal    
DOI: 10.1111/j.1365-2672.2006.03110.x     Document Type: Review

References (43)

1. Anderson, R.M., Dormelly, C.A., Ferguson, N.M., Woolhouse, M.E.J., Watt, C.J., Udy, H.J., MaWhinney, S., Dunstan, S.P. et al. (1996) Transmission dynamics and epidemiology of BSE in British cattle. Nature 382, 779-788.
2. Bessen, R.A., Kocisko, D.A., Raymond, G.J., Nandan, D.A., Lansbury, P.T. and Caughey, B. (1995) Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature 375, 698-700.
3. Blaurock, A.E. and Stoeckenius, W. (1971) Structure of the purple membrane. Nature New Biol 233, 152-155.
4. Brouillette, C.G., McMichens, R.B., Stern, L.J. and Khorana, H.G. (1989) Structure and thermal stability of monomeric bacteriorhodopsin in mixed phospholipid-detergent micelles. Proteins Struc Function Genet 5, 38-46.
5. Brown, P. and Gajdusek, D.C. (1991) Survival of scrapie virus after 3 years' internment. Lancet 337, 269-270.
6. Chappell, C.L., Okhuysen, P.C., Sterling, C.R., Wang, C., Jakubowski, W. and DuPont, H.L. (1999) Infectivity of Cryptosporidium parvum in healthy adults with pre-existing anti-C parvum serum immonoglobulin G. Am J Trop Med Hyg 60, 157-164.
7. Comer, P.J. and Huntly, P.J. (2004) Exposure of the human population to BSE infectivity over the course of the BSE epidemic in Great Britain and the impact of changes to the Over Thirty Month Rule. J Risk Res 7, 523-543.
8. Critchley, P., Kazlauskaite, J., Eason, R. and Pinheiro, T.J.T. (2004) Binding of prion proteins to lipid membranes. Biochem Biophys Res Commun 313, 559-567.
9. Eberl, H., Tittmann, P. and Glockshuber, R. (2004) Characterisation of recombinant, membrane-attached full-length pri3 on protein. J Biol Chem 279, 25058-25065.
10. Gabizon, R., McKinley, M.P. and Prusiner, S.B. (1987) Purified prion proteins and scrapie infectivity copartition into liposomes. Proc Natl Acad Sci USA 84, 4017-4021.
11. 2H-NMR studies of protein/lipid interactions. Biochem Biophys Res Commun 192, 1042-1048.
12. Gale, P. (1998) Quantitative BSE risk assessment: relating exposures to risk. Lett Appl Microbiol 27, 239-242.
13. Gale, P. (2001) A review: developments in microbiological risk assessment. J Appl Microbiol 91, 191-205.
14. Gale, P. (2005) Matrix effects, nonuniform reduction and dispersion in risk assessment for Escherichia coli O157. J Appl Microbiol 99, 259-270.
15. Gale, P. (2006) BSE risk assessments in the UK: a risk tradeoff? J Appl Microbiol 100, 417-427.
16. Gale, P. and Stanfield, G. (2001) Towards a quantitative risk assessment for BSE in sewage sludge. J Appl Microbiol 91, 563-569.
17. 2H-NMR study. Biochim Biophys Acta 1106, 317-324.
18. Gale, P., Young, C., Stanfield, G. and Oakes, D. (1998) Development of a risk assessment for BSE in the aquatic environment. J Appl Microbiol 84, 467-477.
19. Gravenor, M.B., Stallard, N., Curnow, R. and McLean, A.R. (2003) Repeated challenge with prion disease: the risk of infection and impact on incubation period. Proc Natl Acad Sci USA 100, 10960-10965.
20. Head, M.W. and Ironside, J.W. (2005) Mad cows and monkey business. Lancet 365, 730-731.
21. Hu, Z., Troester, M. and Perou, C.M. (2005) High reproducibility using sodium hydroxide-stripped long oligonucleotide DNA microarrays. BioTechniques 38, 121-124.
22. Jacquemot, C., Cuche, C., Dormont, D. and Lazarini, F. (2005) High incidence of scrapie induced by repeated injections of subinfectious prion doses. J Virol 79, 8904-8908.
23. Kimberlin, R.H. (1996) Bovine spongiform encephalopathy and public health: some problems and solutions in assessing risks. In Transmissible Subacute Spongiform Encephalopathies: Prion Diseases ed. Court, L. and Dodet, B. pp. 487-503. Paris: Elsevier.
24. Kimberlin, R.H. and Wilesmith, J.W. (1994) Bovine spongiform encephalopathy (BSE): epidemiology, low dose exposure and risk. Ann NY Acad Sci 724, 210-220.
25. Kulkarni, R.V., Slepoy, A., Singh, R.R.P., Cox, D.L. and Pázmándi, F. (2003) Theoretical modeling of priori disease incubation. Biophys J 85, 707-718.
26. Lasmézas, C.I., Comoy, E., Hawkins, S., Herzog, C., Mouthon, F., Konoid, T., Auvré, F., Correia, E. et al. (2005) Risk of oral infection with bovine spongiform encephalopathy agent in primates. Lancet 365, 781-783.
27. Lloyd, S.E., Onwuazor, O.N., Beck, J.A., Mallinson, G., Farrall, M., Targonski, P., Collinge, J. and Fisher, E.M.C. (2001) Identification of multiple quantitative trait loci linked to prion disease incubation period in mice. Proc Natl Acad Sci USA 98, 6279-6283.
28. Magzoub, M., Oglȩcka, K., Pramanik, A., Goran Eriksson, L.E. and Gärslund, A. (2005) Membrane perturbation effects of peptides derived from the N-termini of unprocessed prion proteins. Biochim Biophys Acta 1716, 126-136.
29. Manolakou, K., Beaton, J., McConnell, I., Farquar, C., Manson, J., Hastie, N.D., Bruce, M. and Jackson, I.J. (2001) Genetic and environmental factors modify bovine spongiform encephalopathy incubation period in mice. Proc Natl Acad Sci USA 98, 7402-7407.
30. McLean, A. and Bostock, C.J. (2000) Scrapie infections initiated at varying doses: an analysis of 117 titration experiments. Philos Trans R Soc Lond B 355, 1043-1050.
31. Meynell, G.G. and Maw, J. (1968) Evidence for a two-stage model of microbial infection. J Hyg 66, 273-280.
32. Meynell, G.G. and Meynell, E.W. (1958) The growth of micro-organisms in vivo with particular reference to the relation between dose and latent period. J Hyg 56, 323-346.
33. Morillas, M., Swietnicki, W., Gambetti, P. and Surewicz, W.K. (1999) Membrane environment alters the conformational structure of the recombinant human prion protein. J Biol Chem 274, 36859-36865.
34. Nowak, M., Krakauer, D.C., Klug, A. and May, R.M. (1998) Prion infection dynamics. Integr Biol 1, 3-15.
35. Somerville, R.A., Oberthur, R.G., Havekost, U., MacDonald, F., Taylor, D.M. and Dickinson, A.G. (2002) Characterisation of thermodynamic diversity between transmissible spongiform encephalopathy agent strains and its theoretical implications. J Biol Chem 277, 11084-11089.
36. Sternberg, B., Gale, P. and Watts, A. (1989) The effect of temperature and protein content on the dispersive properties of bacteriorhodopsin from H. halobium in reconstituted DMPC complexes free of endogenous purple membrane lipids: a freeze-fracture electron microscopy study. Biochim Biophys Acta 980, 117-126.
37. Sternberg, B., L'Hostis, C., Whiteway, C.A. and Watts, A. (1992) The essential role of specific Halobacterium halobium polar lipids in 2D-array formation of bacteriorhodopsin. Biochim Biophys Acta 1108, 21-30.
38. Taylor, D.M. and Fernie, K. (1996) Exposure to autoclaving or sodium hydroxide extends the dose-response curve of the 263K strain of scrapie agent in hamsters. J Gen Virol 77, 811-813.
39. Taylor, D.M., Woodgate, S.L. and Atkinson, M.J. (1995) Inactivation of the bovine spongiform encephalopathy agent by rendering procedures. Vet Rec 137, 605-610.
40. Taylor, D.M., Fernie, K., Steele, P.J., McConnell, I. and Somerville, R.A. (2002) Thermostability of mouse-passaged BSE and scrapie is independent of host PrP genotype: implications for the nature of the causal agents. J Gen Virol 83, 3199-3204.
41. Teunis, P.F.M. and Havelaar, A.H. (2000) The beta Poisson dose-response model is not a single-hit model. Risk Anal 20, 513-520.
42. Watts, A. (1998) Solid-state NMR approaches for studying the interaction of peptides and proteins with membranes. Biochim Biophys Acta 1376, 297-318.
43. Wille, H, Michelitsch, M.D., Guenebaut, V., Supattapone, S., Serban, A., Cohen, F.E., Agard, D.A. and Prusiner, S.B. (2002) Structural studies of the scrapie prions protein by electron crystallography. Proc Natl Acad Sci USA 99, 3563-3568.